[Fetal surgery]

Duodecim; Laaketieteellinen Aikakauskirja
|June 1, 2013
PubMed

Insights

Prenatal treatment for congenital anomalies offers hope, but requires further research and ethical consideration. Future gene and stem cell therapies promise revolutionary advancements in fetal medicine.

Area of Science:

  • Medical Science
  • Genetics
  • Pediatrics

Context:

  • Congenital anomalies pose significant risks, including death and disability, despite optimal postnatal care.
  • Advances in diagnostics, prenatal prognosis, and surgical techniques facilitate prenatal interventions for specific conditions.

Purpose:

  • To explore the current landscape and future potential of prenatal treatment for congenital anomalies.
  • To highlight the need for further research and ethical evaluation in fetal medicine.

Summary:

  • Prenatal treatment is emerging for congenital anomalies, leveraging improved diagnostics and surgical methods.
  • While promising, current evidence from randomized studies is limited, and ethical considerations are paramount.
  • Future therapeutic avenues include gene therapy, stem cell treatments, and tissue engineering.

Impact:

  • Prenatal interventions can potentially improve outcomes for infants with congenital anomalies.
  • Further research and ethical frameworks are crucial for advancing fetal surgery and novel therapies.
  • Emerging technologies like gene and stem cell therapies may revolutionize the management of congenital conditions.